PCAS: 21% increase in sales by 2022
Pharmaceutical synthesis sales came to 143.7 million euros, up 20.1% (+17.6% at constant exchange rates), while fine specialty chemicals sales came to 82.7 million, up 22.7% (+18.6% at constant exchange rates).
Although it is not possible at this stage to assess more precisely the impact on future sales and earnings forecasts due to the legal proceedings in progress', the return to positive results, announced for 2023, has been postponed.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction